• 제목/요약/키워드: Drug Effect

검색결과 3,360건 처리시간 0.029초

건강 상태와 약물오남용 행위 사이에서 자기효능감의 매개효과 (Mediation Effect of Self-efficacy between Health Status and Drug Abuse Behavior)

  • 박경래;장하영
    • 한국임상약학회지
    • /
    • 제28권3호
    • /
    • pp.238-242
    • /
    • 2018
  • Background: The appropriate use of drugs is very important for a healthy life, as appropriate medication must be taken correctly for successful treatment of a disease. The purpose of this study was to investigate the self-efficacy between health status and drug abuse behavior. Methods: The subjects of this study were selected from 15 workshops located in Seoul, Incheon, Daejeon, and Chungnam, and, convenience sampling was conducted for each employee between September, 2017 and October 2017. A total of 204 questionnaires were analyzed. The questions evaluated health status, self-efficacy, drug abuse behavior, and general characteristics. Results: First, there was no difference in health status according to the general characteristics of the subjects. The self-efficacy varied according to gender, educational background, and monthly income, but not by marital status and residence area. In addition, drug abuse behaviors differed according to gender, residence area, and monthly income, but not by marital status and education level. Second, drug abuse behavior negatively correlated with health status and self-efficacy. Third, regression analysis showed that the self-efficacy between the health status and drug abuse behavior had a partially mediating effect. Conclusion: In patients with poor health status, it is necessary to increase their self-efficacy to reduce reduce drug abuse. Therefore, regular education programs targeting efficacy and drug knowledge are required in the community.

교차결합제 구조가 콘택트렌즈의 약물용출 및 항균효과에 미치는 영향 (Effect of Crosslinking Agent Structure on Drug Release and Antibacterial Effect of Contact Lenses)

  • 이필헌;이현미
    • 대한화학회지
    • /
    • 제65권5호
    • /
    • pp.320-326
    • /
    • 2021
  • 본 연구는 콘택트렌즈를 중합 시 사용하는 교차결합제의 구조가 콘택트렌즈의 물리적 특성 및 약물 용출에 미치는 영향을 조사하였다. 4종의 교차결합제를 0.3%와 3%를 각각 사용하여 콘택트렌즈를 제작하였으며 약물은 안약에 사용하는 ofloxacin을 사용하였다. 친수성 교차결합제를 사용한 콘택트렌즈는 함수율과 습윤성이 향상되었으며 친수성 작용기가 많을수록 효과가 크게 나타났다. 약물용출 농도는 친수성이 강한 교차결합제 사용 시 가장 높게 나타났으며 교차결합제의 농도가 높은 콘택트렌즈는 용출되는 약물 농도가 낮고 용출시간은 길어졌다. 콘택트렌즈의 교차결합제 구조는 콘택트렌즈의 성능 향상과 약물 방출조절에 영향을 주었다.

The Modifying Effect of Indole-3-Carbinol (I3C) in rat mammary carcinogenesis

  • Kang, Jin-Seok;Nam, Ki-Taek;Byeongwoo Ahn;Park, Mi-Na;Kim, Ki-Sok;Jang, Dong-Deuk;Kim, Dae-Joong
    • 한국수의병리학회:학술대회논문집
    • /
    • 한국수의병리학회 2000년도 추계학술대회 및 정기총회
    • /
    • pp.26-26
    • /
    • 2000
  • The consumption of cruciferous vegetables such as cabbage and broccoli have been shown to have a chemopreventive effect in human and in experimental animals. Indole-3-carbinol (I3C), one component of cruciferous vegetables, has been shown to exert its chemopreventive effect in liver, colon and mammary tissue before or concurrent exposure of carcinogen, but in some reports, there have been several evidence that consumption of I3C after carcinogen treatment induced tumor promotion in some tissues. There have been no reports about the effect of I3C after carcinogen exposure in N-Nitroso-N-methylurea (MNU)-induced mammary tumor model of rats. (omitted)

  • PDF

Geometry effect in the drug delivery for therapy with nanomedicines based on the conditions of the sport

  • Zhu, Lemei;Zou, Xuemin;Li, Xi;Zhang, Yuan;Liu, Juan;Xiang, Yuhan
    • Advances in nano research
    • /
    • 제13권3호
    • /
    • pp.217-231
    • /
    • 2022
  • This study investigates the geometrical impact on the nanomedicine drug delivery via nanodevices. A nanomotor made of the nanotube carrying the drug as the motor blade is considered in the blood flow. Physical activities change the blood flow, and sports training enhances the blood flow and plays a significant role in the stability of drug delivery devices. This paper studies the impact of geometrical parameters on the nanomotors carrying the nanomedicine. The effect of physical exercise on the dynamic response regarding the stability of drug delivery devices is discussed in detail.

호흡기질환 송아지의 침술요법에 관한 연구 (Studies on the Acupuncture Therapy for Respiratory Diseases in Calves)

  • 조용성
    • 한국임상수의학회지
    • /
    • 제14권1호
    • /
    • pp.88-92
    • /
    • 1997
  • The present experiment was investigated to compare tretment effect of drug therapy, acupuncture therapy, the combination of acupuncture and drug therapy, and electro-acupuncture therapy using 152 calves with respiratory deseases. Among 20 cases of drug therapy group, 16 cases (80%) were recovered and 4 cases (20%) were ineffective. Among 28 cases using Su Qi in acupuncture therapy group, 21 cases using San Tai, An Bi and Fei Shu, 17 cases (72%) were available and 7 cases (28%) were unavailable. Among 28 cases of the combination group of acupuncture and drug therapy, 24 cases(86%) were recovered with the highest tretment effect in Su Qi and drug therapy. In addition, among 24 cases of the combination group of acupuncture and drug therapy, 20 cases(84%) were effective and 4 cases (16%) were ineffective with lower effective rate compared by Su Qi and drug therapy in San tai, An bi and Fei shu and drug therapy. And among electro-acupuncture group using Fei Shu $[left({\ominus}), right({\oplus})],$ 22 cases (82%) were effective and 6 cases (18%) were ineffective.

  • PDF

In Vitro Pharmacodynamics of CKD-602 in HT-29 Cells

  • Park, In-Sook;Ahn, Mee-Ryung;Suh, Soo-Kyung;Choi, Hong-Serck;Sohn, Soo-Jung;Yang, Ji-Sun;Yoo, Tae-Moo;Kuh, Hyo-Jeong
    • Archives of Pharmacal Research
    • /
    • 제25권5호
    • /
    • pp.718-723
    • /
    • 2002
  • CKD-602 (7-[2-(N-isopropylamino)ethyl]-(20S)-camptothecin) is a recently-developed synthetic camptothecin analogue and currently under clinical development by Chong Kun Dang Pharm (Seoul, Korea). CKD-602 showed potent topoisomerase inhibitory activity in vitro and broad antitumor activity against various human tumor cells in vitro and in vivo in animal models. This study describes the pharmacodynamics of the immediate and delayed cytotoxicity induced by CKD-602 in a human colorectal adenocarcinoma cell line, HT-29, and its intracellular drug accumulation by HPLC. The present study was designed to address whether the higher activity of CKD-602 with prolonged exposure is due to delayed exhibition of cytotoxicity and/or an accumulation of anti proliferative effect on continuous drug exposure. The drug uptake study was performed to determine whether the delayed cytotoxicity is due to a slow drug accumulation in cells. CKD-602 produced a cytotoxicity that was exhibited immediately after treatment (immediate effect) and after treatment had been terminated (delayed effect). Both the immediate and delayed effects of CKD-602 showed a time dependent decrease in 4IC_{50}$ values. Drug uptake was biphasic and the second equilibrium level was obtained as early as at 24hr, indicating that the cumulative and delayed antitumor effects of CKD-602 were not due to slow drug uptake. On the other hand, CKD-602 treatment was sufficient to induce delayed cytotoxicity after 4hr, however, longer treatment (>24hr) enhanced its cytotoxicity due to the intracellular accumulation of the drug, which requires 24hr to reach maximum equilibrium concentration. In addition, $C^n$$\times$T=h analysis (n=0.481) indicated that increased exposure times may contribute more to the overall antitumor activity of CKD-602 than drug concentration. Additional studies to determine the details of the intracellular uptake kinetics (e.g., concentration dependency and retention studies) are needed in order to identify the optimal treatment schedules for the successful clinical development of CKD-602.

소화관에서의 약물 흡수에 대한 음식물의 영향 (The Effect of Food on Absorption of Drug in the Gastrointestinal Tract)

  • 윤휘열;백민선;권광일
    • 한국임상약학회지
    • /
    • 제16권2호
    • /
    • pp.147-154
    • /
    • 2006
  • Drugs are often taken together with meals and there are numerous opportunity for food-drug interaction to occure. Food-drug interactions and their clinical consequences are very complex indeed. The composition of the meal, and the volume of fluid that is ingested often are decisive factors in food-drug interactions. Various formulations of a specific drug may behave differently. Solutions and suspensions seem to be less susceptible and enteric-coated preparations are more susceptible, to food interactions than are other dosage forms but exceptions to this rule do exist. Furthermore, generic and environmental factors, disease and other drugs cause considerable inter- and intraindividual variation in food-drug interactions. Also, eating habits are dissimilar in different parts of the world, and diets often vary greatly from day to day. The taking of drugs together with meals offers some obvious benefits. It may help to reduce gastrointestinal irritation and compliance is improved. On the other hand, in some cases food interferes seriously with drug absorption. The purpose of this review is to clarify the complexity of food-drug interactions, and to discuss interactions that may be of clinical importance.

  • PDF

약물계량학을 이용한 초기임상1상 시험 용량 예측 방법에 대한 비교연구 (Comparative Study of First-in-Human Dose Estimation Approaches using Pharmacometrics)

  • 백인환
    • 한국임상약학회지
    • /
    • 제26권2호
    • /
    • pp.150-162
    • /
    • 2016
  • Objective: First-in-human dose estimation is an essential approach for successful clinical trials for drug development. In this study, we systematically compared first-in-human dose and human pharmacokinetic parameter estimation approaches. Methods: First-in-human dose estimation approaches divided into similar drug comparison approaches, regulatory guidance based approaches, and pharmacokinetic based approaches. Human clearance, volume of distribution and bioavailability were classified for human pharmacokinetic parameter estimation approaches. Results: Similar drug comparison approaches is simple and appropriate me-too drug. Regulatory guidance based approaches is recommended from US Food and Drug Administration (FDA) and European Medicines Agency (EMA) regarding no-observed-adverse-effect level (NOAEL) or minimum anticipated biological effect level (MABEL). Pharmacokinetic based approaches are 8 approaches for human clearance estimation, 5 approaches for human volume of distribution, and 4 approaches for human bioavailability. Conclusion: This study introduced and compared all methods for first-in-human dose estimation. It would be useful practically to estimate first-in-human dose for drug development.

Effect of Drug Loading on the Physicochemical Properties and Stability of Cationic Lipid-based Plasmid DNA Complexes

  • Jeong, Ui-Hyeon;Jung, Ji-Hye;Davaa, Enkhzaya;Park, Se-Jin;Myung, Chang-Seon;Park, Jeong-Sook
    • Journal of Pharmaceutical Investigation
    • /
    • 제39권5호
    • /
    • pp.339-343
    • /
    • 2009
  • Recently, co-delivery of drug and gene has been attempted for higher therapeutic effects of anticancer agents. In this study, cationic liposomes were prepared using 1,2-dioleoyl-3-trimethylammoniopropane (DOTAP) as a cationic lipid to investigate the effect of drug loading on the physicochemical characteristics of cationic liposomes/DNA complexes. The complex formation between cationic liposomes and negatively charged plasmid DNA was confirmed and the protection from DNase was observed. Particle size of complexes was reduced not by drug loading, but by the increased ratio of cationic lipid to plasmid DNA. Meanwhile, zeta potential of complex was increased by the addition of cationic liposomes to complexes and the effect of drug loading on the zeta potential was not much higher than on particle size. Gel retardation of complexes was indicated when the complexation weight ratios of cationic lipid to plasmid DNA were higher than 24:1 for drug free complexes and 20:1 for drug loaded ones, respectively. Agarose gel retardation showed the similar complexation between plasmid DNA and drug free liposomes or drug loaded liposomes. Both complexes protected plasmid DNA from DNase independent of complexation temperature. From the results, drug loading may affect not the complex formation of cationic liposomes and plasmid DNA, but the particle size of complex.